Two Additional Variants Expand the Genotypic Spectrum of Dominant Calpain‐3 Deficiencies
Clinical Case Reports · 2026-11 · 14 (11)
DOI: 10.1002/ccr3.73848 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Case Reports, online erschienen am 02.11.2026. Verfasst von Thomas Krag und 3 weiteren Autor:innen. Beteiligte Einrichtung: Copenhagen Neuromuscular Center Copenhagen University Hospital Rigshospitalet, University of Copenhagen Copenhagen Denmark. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Limb‐girdle muscular dystrophy type D4 is caused by a single pathogenic variant of the CAPN3 gene coding for calpain‐3 and is clinically milder than the more common recessive form, type R1. It is likely underdiagnosed, and expanding the phenotype–genotype relationship is needed to establish a clinical guideline for this disorder.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Copenhagen Neuromuscular Center Copenhagen University Hospital Rigshospitalet, University of Copenhagen Copenhagen Denmark.
- Department of Clinical Genetics Copenhagen University Hospital Rigshospitalet, University of Copenhagen Copenhagen Denmark.
ORCID-Profile: Thomas Krag, Morten Dunø, Nanna Witting, John Vissing
Zitieren
APA
Krag, T., Dunø, M., Witting, N., & Vissing, J. (2026). Two Additional Variants Expand the Genotypic Spectrum of Dominant Calpain‐3 Deficiencies. Clinical Case Reports, 14(11). https://doi.org/10.1002/ccr3.73848
Vancouver
Krag T, Dunø M, Witting N, Vissing J. Two Additional Variants Expand the Genotypic Spectrum of Dominant Calpain‐3 Deficiencies. Clinical Case Reports. 2026;14(11). doi:10.1002/ccr3.73848
BibTeX
@article{Krag2026,
author = {Krag, Thomas and Dunø, Morten and Witting, Nanna and Vissing, John},
title = {Two Additional Variants Expand the Genotypic Spectrum of Dominant Calpain‐3 Deficiencies},
journal = {Clinical Case Reports},
year = {2026},
volume = {14},
number = {11},
doi = {10.1002/ccr3.73848}
}
EUVIMED